I recently read this morning that the shingles vaccine, Shingrix, “may have a protective effect against dementia.” It goes on ...

A study of more than one million people found the shingles vaccine may lower the risk of heart disease and stroke for up to ...

Shingles is painful, but did you know the vaccine may also help prevent dementia? Learn why I got vaccinated and why it might ...

A Welsh health policy provided a rare opportunity for researchers to examine the vaccine's real-life impact on dementia risk.

A new study suggests the shingles vaccine may reduce the risk of heart disease for up to eight years post-vaccination. A ...

Large and mid-cap vaccine makers are, as of now, unworried about their 2025 pipelines in the face of research funding declines by the Trump administration and a drop in biotech funding.

The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 vaccine as a post-approval commitment, a source familiar with the ...

FRIDAY, April 25, 2025 (HealthDay News) — Novavax’s COVID-19 vaccine could soon receive full approval from the U.S. Food and Drug Administration (FDA), the company said Wednesday. The update ...

GlaxoSmithKline places its shingles vaccine Shingrix among its top prospects, with peak sales potential of almost $6 billion. Now, Pfizer and BioNTech are joining forces to try to grab a slice of ...